Trevor J. Laborda

Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis Consortium

T. Miloh, Amy E Taylor, A. Montano‐Loza, 2020, Journal of pediatric gastroenterology and nutrition.

Hereditary pancreatitis: An updated review in pediatrics

Trevor J. Laborda, E. Rivera-Rivera, Arvind V Panchoo, 2022, World journal of clinical pediatrics.

Treatment of primary sclerosing cholangitis in children

M. Deneau, M. K. Jensen, Trevor J. Laborda, 2019, World journal of hepatology.

Evolution in the Practice of Pediatric Endoscopy and Sedation

Girish Hiremath, J. Kynes, Trevor J. Laborda, 2021, Frontiers in Pediatrics.

Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched Analysis

T. Miloh, N. Kerkar, S. Guthery, 2020, Hepatology.

The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children

T. Miloh, N. Kerkar, S. Guthery, 2020, Hepatology.

Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study

T. Miloh, N. Kerkar, M. Jonas, 2021, Hepatology.

Avoidant/Restrictive Food Intake Disorder in Diet-treated Children With Eosinophilic Esophagitis.

S. Guthery, S. Fitzgerald, M. O'Gorman, 2019, Journal of pediatric gastroenterology and nutrition.

Colorectal Dysplasia and Cancer in Pediatric-onset Ulcerative Colitis Associated with Primary Sclerosing Cholangitis.

T. Miloh, N. Kerkar, S. Guthery, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis‐associated inflammatory bowel disease (PSC‐IBD): A matched analysis from the Paediatric PSC Consortium

B. Kamath, E. Perito, K. Furuya, 2024, Alimentary pharmacology & therapeutics.